AVALIAÇÃO ECONÓMICA DE FIDAXOMICINA NO TRATAMENTO DE INFEÇÕES POR CLOSTRIDIUM DIFFICILE GRAVES OU RECORRENTES

AVALIAÇÃO ECONÓMICA DE FIDAXOMICINA NO TRATAMENTO DE INFEÇÕES POR CLOSTRIDIUM DIFFICILE GRAVES OU RECORRENTES

Show other versions (1)

Objectives: Fidaxomicin is a macrocyclic antibiotic drug indicated for the treatment of Clostridium difficile infections (CDI). The purpose of this study was to evaluate from a societal perspective the cost-effectiveness and cost-utility of fidaxomicin in the treatment of severe or recurrent CDI co...

Full description

Bibliographic Details
Main Authors: Miguel Gouveia, João Costa, Joana Alarcão, Margarida Borges
Format: Article
Language:English
Published: Formifarma, LDA. 2015-11-01
Series:Revista Portuguesa de Farmacoterapia
Subjects:
Clostridium difficile Infections (CDI)
diarrhea
cost-utility
cost-effectiveness
fidaxomicin
Online Access:http://farmacoterapia.pt/index.php/rpf/article/view/39

Similar Items

Similar Items